Terms: = Lymphoma AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025
11 results:
1. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
2. Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.
Groehler A; Villalta PW; Campbell C; Tretyakova N
Chem Res Toxicol; 2016 Feb; 29(2):190-202. PubMed ID: 26692166
[TBL] [Abstract] [Full Text] [Related]
3. Influence of polymorphisms in ERCC5, xpa and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population.
Ruiz-Cosano J; Torres-Moreno D; Conesa-Zamora P
J BUON; 2013; 18(2):486-90. PubMed ID: 23818366
[TBL] [Abstract] [Full Text] [Related]
4. [The relationship between polymorphism of genes xpa, XPC, XPD, XRCC1 and susceptibility to acute lymphoblastic leukemia].
Tang FF; Ouyang J; Xu Y; Zhou RF; Zhou M; Chen B; Zhang QG; Feng X; Zhang X; Chen MM; Zeng Y; Xu YY
Zhonghua Nei Ke Za Zhi; 2011 Oct; 50(10):859-62. PubMed ID: 22321329
[TBL] [Abstract] [Full Text] [Related]
5. p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma.
Kudo I; Esumi M; Kida A; Ikeda M
Oncol Rep; 2010 Oct; 24(4):851-6. PubMed ID: 20811663
[TBL] [Abstract] [Full Text] [Related]
6. [Genetic susceptibility of single nucleotide polymorphism in MGMT to non-Hodgkin lymphoma].
Yang F; Shi JY; Xu L; Ren LJ; Zhang QH; Zhao WL; Shen ZX
Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):622-5. PubMed ID: 19954624
[TBL] [Abstract] [Full Text] [Related]
7. Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone.
Abernethy DJ; Kleymenova EV; Rose J; Recio L; Faiola B
Toxicol Sci; 2004 May; 79(1):82-9. PubMed ID: 14976336
[TBL] [Abstract] [Full Text] [Related]
8. Nucleotide excision repair-deficient human cells in culture exhibit decreased survival after 2-chlorodeoxyadenosine treatment.
Lawrenzi J; Bunnell A; Hentosh P
Anticancer Res; 2003; 23(4):3141-5. PubMed ID: 12926046
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation on carcinogenicity of chemicals using transgenic mice.
Mitsumori K
Toxicology; 2002 Dec; 181-182():241-4. PubMed ID: 12505318
[TBL] [Abstract] [Full Text] [Related]
10. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient xpa mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract] [Full Text] [Related]
11. Use of DNA repair-deficient xpa transgenic mice in short-term carcinogenicity testing.
van Steeg H; Klein H; Beems RB; van Kreijl CF
Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
[TBL] [Abstract] [Full Text] [Related]
